| # | Country | Total Patents | |
|---|---|---|---|
| #1 | China | 3 | |
| #2 | EPO (European Patent Office) | 3 | |
| #3 | WIPO (World Intellectual Property Organization) | 3 | |
| #4 | Hong Kong | 2 | |
| #5 | Japan | 1 | |
| #6 | United States | 1 |
| # | Industry | |
|---|---|---|
| #1 | Pharmaceuticals | |
| #2 | Organic fine chemistry | |
| #3 | Biotechnology |
| # | Technology | |
|---|---|---|
| #1 | Heterocyclic compounds | |
| #2 | Therapeutic chemical compounds | |
| #3 | Microorganisms | |
| #4 | Medical preparations |
| # | Name | Total Patents |
|---|---|---|
| #1 | Huang Haihong | 13 |
| #2 | Yu Chunrong | 13 |
| #3 | Li Peng | 10 |
| #4 | Zhang Dongfeng | 10 |
| #5 | Li Lianhai | 3 |
| Publication | Filing date | Title |
|---|---|---|
| WO2017186148A1 | Novel heterocyclic compounds as tyrosine kinase bcr-abl inhibitors | |
| WO2016029776A1 | Protein kinase inhibitors | |
| US2014364436A1 | Protein kinase inhibitors | |
| WO2014019338A1 | Protein kinase inhibitors |